NEWEST DIPLOMATE OF THE AMERICAN
BOARD OF TOXICOLOGY CERTIFICATION
EXAM OFFERED BY AMERICAN BOARD OF
TOXICOLOGY, INC.| COMPLETE EXAM Q&A
WITH RATIONALES
1. A new chemical entity has an elimination half‑life of
6 hours. How long after dosing will it be cleared to
approximately 97% of the administered dose,
assuming first‑order kinetics?
A) 12 hours
B) 24 hours
C) 30 hours
D) 48 hours
Correct answer: C
Rationale: First‑order elimination clears about 97%
after five half‑lives (6 × 5 = 30 hours). Each half‑life
reduces the concentration by half.
**2.** A study reports an LD50 of 500 mg/kg for a
pesticide via oral route in rats. How is this best
interpreted?
,A) 500 mg/kg is the minimum dose that causes death
in any rat
B) 500 mg/kg is the dose that kills 50% of the test
animal population
C) 500 mg/kg is the dose that causes toxic effects in
50% of the rats
D) 500 mg/kg is the safe dose for humans
Correct answer: B
Rationale: LD50 is the statistically derived dose
expected to kill 50% of a test animal population under
controlled conditions.
**3.** An in vitro Ames test is positive for
mutagenicity. Which of the following is the most
appropriate conclusion?
A) The test substance is definitely a human
carcinogen
B) The test substance is likely an in vivo mutagen and
a potential carcinogen
C) The test substance is safe for human exposure
,D) The test substance is not a carcinogen
Correct answer: B
Rationale: Mutagens are potential carcinogens;
further in vivo testing is needed.
**4.** A chemical is highly lipophilic and has a large
volume of distribution (Vd). This indicates that the
chemical:
A) Is primarily confined to the blood plasma
B) Is extensively distributed into tissues
C) Is rapidly excreted by the kidneys
D) Has poor absorption from the gut
Correct answer: B
Rationale: Large Vd indicates extensive tissue
distribution beyond plasma volume; lipophilic
chemicals often have large Vd.
**5.** Which of the following study types is most
commonly used as the primary data source for
deriving a Reference Dose (RfD)?
, A) Acute lethality study (LD50)
B) In vitro mutagenicity assay (Ames test)
C) Subchronic or chronic toxicity study (e.g., 90‑day
or 2‑year rodent study)
D) Skin irritation test
Correct answer: C
Rationale: RfD is derived from NOAEL/LOAEL in
subchronic or chronic studies where endpoints
relevant to non‑cancer effects are observed.
**6.** A new drug candidate shows a steep
dose‑response curve. This implies that:
A) A small increase in dose leads to a large increase
in response
B) A large increase in dose is required to see any
response
C) The drug is not effective
D) The drug has a wide safety margin
Correct answer: A
BOARD OF TOXICOLOGY CERTIFICATION
EXAM OFFERED BY AMERICAN BOARD OF
TOXICOLOGY, INC.| COMPLETE EXAM Q&A
WITH RATIONALES
1. A new chemical entity has an elimination half‑life of
6 hours. How long after dosing will it be cleared to
approximately 97% of the administered dose,
assuming first‑order kinetics?
A) 12 hours
B) 24 hours
C) 30 hours
D) 48 hours
Correct answer: C
Rationale: First‑order elimination clears about 97%
after five half‑lives (6 × 5 = 30 hours). Each half‑life
reduces the concentration by half.
**2.** A study reports an LD50 of 500 mg/kg for a
pesticide via oral route in rats. How is this best
interpreted?
,A) 500 mg/kg is the minimum dose that causes death
in any rat
B) 500 mg/kg is the dose that kills 50% of the test
animal population
C) 500 mg/kg is the dose that causes toxic effects in
50% of the rats
D) 500 mg/kg is the safe dose for humans
Correct answer: B
Rationale: LD50 is the statistically derived dose
expected to kill 50% of a test animal population under
controlled conditions.
**3.** An in vitro Ames test is positive for
mutagenicity. Which of the following is the most
appropriate conclusion?
A) The test substance is definitely a human
carcinogen
B) The test substance is likely an in vivo mutagen and
a potential carcinogen
C) The test substance is safe for human exposure
,D) The test substance is not a carcinogen
Correct answer: B
Rationale: Mutagens are potential carcinogens;
further in vivo testing is needed.
**4.** A chemical is highly lipophilic and has a large
volume of distribution (Vd). This indicates that the
chemical:
A) Is primarily confined to the blood plasma
B) Is extensively distributed into tissues
C) Is rapidly excreted by the kidneys
D) Has poor absorption from the gut
Correct answer: B
Rationale: Large Vd indicates extensive tissue
distribution beyond plasma volume; lipophilic
chemicals often have large Vd.
**5.** Which of the following study types is most
commonly used as the primary data source for
deriving a Reference Dose (RfD)?
, A) Acute lethality study (LD50)
B) In vitro mutagenicity assay (Ames test)
C) Subchronic or chronic toxicity study (e.g., 90‑day
or 2‑year rodent study)
D) Skin irritation test
Correct answer: C
Rationale: RfD is derived from NOAEL/LOAEL in
subchronic or chronic studies where endpoints
relevant to non‑cancer effects are observed.
**6.** A new drug candidate shows a steep
dose‑response curve. This implies that:
A) A small increase in dose leads to a large increase
in response
B) A large increase in dose is required to see any
response
C) The drug is not effective
D) The drug has a wide safety margin
Correct answer: A
